作者| 高凌朗编辑| 汪戈伐7月10日晚间,药明康德一纸业绩预告让医药板块瞬间躁动。公司预计2025年上半年实现营收208亿元,同比增长20.64%;归母净利润85.61亿元,增幅达到101.92%。这个数字让市场颇感意外——去年同期,这家CXO龙头的净利润还不到43亿元。11日开盘,药明康德A股封死涨停,港股也一度暴涨超10%。市场用最直接的方式表达了对这份成绩单的认可。更重要的,是这份业绩预告...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.